StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$18.18−0.79 (-4.16%)

Close on Nov 17, 2026Market cap $1.12BP/E –Yield –

Vor Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Vor Biopharma

Vor Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vor Biopharma figures

See a number that looks wrong?